237 related articles for article (PubMed ID: 36548957)
1. How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia.
Kopmar NE; Cassaday RD
Blood; 2023 Mar; 141(12):1379-1388. PubMed ID: 36548957
[TBL] [Abstract][Full Text] [Related]
2. Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management.
Paul S; Short NJ
Curr Oncol Rep; 2022 Apr; 24(4):427-436. PubMed ID: 35141858
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Hamdi A; Mawad R; Bassett R; di Stasi A; Ferro R; Afrough A; Ram R; Dabaja B; Rondon G; Champlin R; Sandmaier BM; Doney K; Bar M; Kebriaei P
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1767-71. PubMed ID: 25017763
[TBL] [Abstract][Full Text] [Related]
5. Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia.
Aldoss I; Al Malki MM; Stiller T; Cao T; Sanchez JF; Palmer J; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2016 Mar; 22(3):575-8. PubMed ID: 26493564
[TBL] [Abstract][Full Text] [Related]
6. ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation.
Sauter CS; DeFilipp Z; Inamoto Y; Johnston L; Nagler A; Savani BN; Carpenter PA; Perales MA
Biol Blood Marrow Transplant; 2019 Mar; 25(3):e86-e88. PubMed ID: 30590125
[TBL] [Abstract][Full Text] [Related]
7. Radiation-Free myeloablative allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia: A comparison of outcomes between patients with and without central nervous system involvement.
Esfandbod M; Enshaei M; Monzavi SM; Kabootari M; Behfar M; Hamidieh AA
Leuk Res; 2021 Dec; 111():106703. PubMed ID: 34534907
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system disease in hematologic malignancies: historical perspective and practical applications.
Pui CH; Thiel E
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S2-S16. PubMed ID: 19660680
[TBL] [Abstract][Full Text] [Related]
9. Central Nervous System Prophylaxis and Treatment in Acute Leukemias.
Wu SY; Short NJ; Nasr L; Dabaja BS; Fang PQ
Curr Treat Options Oncol; 2022 Dec; 23(12):1829-1844. PubMed ID: 36510037
[TBL] [Abstract][Full Text] [Related]
10. Augmenting Total Body Irradiation with a Cranial Boost before Stem Cell Transplantation Protects Against Post-Transplant Central Nervous System Relapse in Acute Lymphoblastic Leukemia.
Gao RW; Dusenbery KE; Cao Q; Smith AR; Yuan J
Biol Blood Marrow Transplant; 2018 Mar; 24(3):501-506. PubMed ID: 29191665
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis and therapy of central nervous system involvement in adult acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
Giebel S; Krawczyk-Kuliś M; Adamczyk-Cioch M; Czyz A; Lech-Marańda E; Piatkowska-Jakubas B; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
Pol Arch Med Wewn; 2008 Jun; 118(6):356-61. PubMed ID: 18619191
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of prophylactic additional cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL.
Fukano R; Nishimura M; Ito N; Nakashima K; Kodama Y; Okamura J; Inagaki J
Pediatr Transplant; 2014 Aug; 18(5):518-23. PubMed ID: 24815062
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
14. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
Ribeiro RC; Rivera GK; Hudson M; Mulhern RK; Hancock ML; Kun L; Mahmoud H; Sandlund JT; Crist WM; Pui CH
J Clin Oncol; 1995 Feb; 13(2):333-8. PubMed ID: 7844594
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature.
Yoshihara T; Morimoto A; Kuroda H; Imamura T; Ishida H; Tsunamoto K; Naya M; Hibi S; Todo S; Imashuku S
Bone Marrow Transplant; 2006 Jan; 37(1):25-31. PubMed ID: 16247416
[TBL] [Abstract][Full Text] [Related]
16. Outcome Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia Treated with Total Body Irradiation-Free Allogeneic Hematopoietic Stem Cell Transplantation: Comparison of Patients with and Without Central Nervous System Involvement.
Hamidieh AA; Monzavi SM; Kaboutari M; Behfar M; Esfandbod M
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2110-2117. PubMed ID: 28870778
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation.
Oshima K; Kanda Y; Yamashita T; Takahashi S; Mori T; Nakaseko C; Fujimaki K; Yokota A; Fujisawa S; Matsushima T; Fujita H; Sakura T; Okamoto S; Maruta A; Sakamaki H;
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1100-1107. PubMed ID: 18804039
[TBL] [Abstract][Full Text] [Related]
18. Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia.
McNeer JL; Schmiegelow K
Curr Hematol Malig Rep; 2022 Feb; 17(1):1-14. PubMed ID: 35025035
[TBL] [Abstract][Full Text] [Related]
19. The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.
Cortes J; O'Brien SM; Pierce S; Keating MJ; Freireich EJ; Kantarjian HM
Blood; 1995 Sep; 86(6):2091-7. PubMed ID: 7662956
[TBL] [Abstract][Full Text] [Related]
20. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
